Protherics PLC
Notification of Major Interests in Shares
London, UK; Brentwood, TN, US: 4 July 2008 - Protherics PLC
("Protherics" or the "Company"), the international
biopharmaceutical
company focused on critical care and cancer, announces that on 3
July 2008, in accordance with the Transparency Obligations
Directive, a notification of interest in the ordinary share
capital of
the Company was received from AXA Investment Managers UK Limited
on
behalf of AXA S.A. and its Group Companies ("AXA"). The
notification
follows a disposal of voting rights. Details of
the interest notified are as follows:
1. Reason for the notification (please tick the appropriate box
or
boxes)
A disposal of voting rights
X
An acquisition or disposal of financial instruments which may
result
in the acquisition of shares already issued to which voting rights
are attached
An event changing the breakdown of voting rights
Other (please specify):
2. Full name of person(s) subject to the AXA S.A., 25 Avenue
Matignon,
notification obligation: 75008 Paris and its group
of
companies.
3. Full name of shareholder(s) (if
different from 2.):
4. Date of the transaction (and date on 2 July 2008
which the threshold is crossed or
reached if different):
5. Date on which issuer notified: 3 July 2008
6. Threshold(s) that is/are crossed or 13%
reached:
7. Notified details:
A: Voting rights attached to shares
Class/ Situation previous to Resulting situation after the
triggering
type of the Triggering transaction
shares transaction
if Number of Number of Number Number of voting % of
voting
possible Shares Voting of rights rights
using Rights shares
the ISIN
CODE Direct Direct Indirect Direct
Indirect
0702920 44,836,830 44,836,830 941,666 941,666 40,774,831 0.28%
11.98%
B: Financial Instruments
Resulting situation after the triggering transaction
Type of Expiration Exercise/ Number of voting rights that %
of
financial date Conversion may be acquired if the
voting
instrument Period/ instrument is exercised/
rights
Date converted.
Total (A+B)
Number of voting rights % of voting rights
41,716,497 12.25%
8. Chain of controlled undertakings through which the voting
rights and
/or the financial instruments are effectively held, if applicable
:
Name of Company/Fund Number of % of issued share
Shares capital
AXA UK Investment Co ICVC 552,143 0.16220
UK Smaller Companies Fund
Indirect
Sun Life Pensions Management Ltd 225,000 0.06610
DirectSun Life Unit Assurance Ltd 53,913 0.01584
FTSE All Share Tracker
Direct
Sun Life Pensions Management 294,874 0.08662
FTSE All Share Tracker
Direct
AXA Framlington 425,000 0.12485
Indirect
AXA Framlington 1,851,468 0.54388
Indirect
AXA Framlington 1,909,918 0.56105
Indirect
AXA Framlington 459,865 0.13509
Indirect
AXA Framlington 639,353 0.18781
Indirect
AXA Framlington 15,438,453 4.53516
Indirect
AXA Framlington 13,753,131 4.04008
Indirect
AXA Framlington 2,000,000 0.58751
Indirect
AXA Framlington 1,500,000 0.44064
Indirect
AXA Framlington 500,000 0.14688
Indirect
AXA Framlington 220,000 0.06463
Indirect
Framlington onshore private 975,500 0.28656
clients
Indirect
AXA Sun Life ith Profits Passive 226,817 0.06663
Direct
AXA Sun Life With Profits 141,062 0.04144
Passive
Direct
AXA Framlington 550,000 0.16157
Indirect
Total Direct 941,666 0.27662
Total Indirect 40,774,831 11.97790
TOTAL 41,716,497 12.25452
Proxy Voting:
9. Name of the proxy holder:
10. Number of voting rights proxy holder will cease to hold:
11. Date on which proxy holder will cease to hold voting rights:
12. Additional information:
/ Ends /
For further information please contact:
Protherics
Nick Staples, Director of Corporate Affairs +44 (0) 7919 480510
Julie Vickers, Company Secretary +44 (0)1928 518010
Financial Dynamics - press enquiries
London: Ben Atwell, Lara Mott +44 (0) 20 7831 3113
New York: John Capodanno +1 212 850 5600
Or visit www.protherics.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
Contact Information: Contacts: RNS Customer Services 0044-207797-4400 http://www.rns.com